pharmaceutical intermediates Hyaluronic Acid (HA) for ophthalmic surgery

 KR ▼

•   DE
•   JP
•   RU
•   IN
•   FR
•   ES
•   IT

• Category : Others
• Place of Origin : Shandong, China
• Payment : L/C,D/P,T/T
• Description :

• pharmaceutical intermediates Hyaluronic Acid (HA) for ophthalmic surgery adopts high-purity refined medical hyaluronate acid which is a kind of ideal adjuvant to ophthalmic operation. With the average molecular weight of 1~2.4 millions, it contains 1-2% medical sodium hyaluronate, has good kinematic viscosity, little deviation, and sufficient functions of forming anterior chamber and protecting corneal endothelium. The substance is a kind of high-viscoelasticity, sterile, non-pyrogenic, and nonantigenic macromolecular polysaccharide biomaterial. The preparation is packed in pre-filling and pre-sealing injector, which is easy to operate in operation.

  Functions and Mechanisms: viscoelastic liner function, pseudoplastic function, tissue isolation function, and viscous blockage function

  Application Scope: intracapsular and extracapsular cataract extraction, keratoplasty, glaucoma surgery, retinal decollement, phacoemulsification, ocular trauma surgery and ocular surgery.

  Ophthalmology:
  1. Intra-/extra-capsular cataract extraction( Intraocular lens implantation)
  2. Corneal transplantation
  3. Glaucomatous operation
  4. Retinal detachment
  5. Phacoemulsification of cataract
  6. Trabecul ectomy
  7. Total iridectomy
  8. Vitreous amputation
  9. Eye injury and ophthalmic surgery

  Specifications: 0.5ml/piece, 0.8ml/piece, 1ml/piece.and 1.5ml/piece